CYCN (Cyclerion Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of May 21, 2026, CYCN trades at $3.02 with a market cap of $13.08M and a P/E ratio of -2.27. CYCN moved +4.33% today. Year to date, CYCN is +123.19%; over the trailing twelve months it is -6.21%. Its 52-week range spans $1.03 to $9.47. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CYCN SEC filings?

Rallies organizes CYCN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CYCN Key Metrics

Key financial metrics for CYCN
MetricValue
Price$3.02
Market Cap$13.08M
P/E Ratio-2.27
EPS$-1.36
Dividend Yield0.00%
52-Week High$9.47
52-Week Low$1.03
Volume42
Avg Volume0
Revenue (TTM)$1.99M
Net Income$-5.28M
Gross Margin0.00%

Latest CYCN News

Recent CYCN Insider Trades

  • Slate Path Capital LP sold 357.88K (~$555.11K) on Nov 21, 2024.
  • MCGUIRE TERRANCE sold 8 (~$27.16) on Aug 9, 2023.
  • MCGUIRE TERRANCE bought 92.83K (~$289.63K) on Jun 3, 2021.

CYCN Analyst Consensus

CYCN analyst coverage data. Average price target: $0.00.

Common questions about CYCN

Where can I find CYCN SEC filings?
Rallies organizes CYCN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CYCN 10-K and 10-Q filings?
Rallies organizes CYCN SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CYCN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CYCN. It does not provide personalized investment advice.
CYCN

CYCN